Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19 EUR | -0.03% | -7.27% | +13.88% |
Jun. 08 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
Jun. 07 | GSK says FDA Approves Expanded Age Indication For Arexvy, RSV Vaccine For Adults Aged 50-59 At Increased Risk | RE |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
---|---|---|---|---|
Last | 19 € | 19.26 € | 19.005 € | 19 € |
Volume | 5 337 | 5 268 | 170 | 0 |
Change | +2.34% | +1.37% | -1.32% | -0.03% |
Opening | 18.55 | 19.21 | 19.22 | 19.05 |
High | 19.56 | 19.30 | 19.53 | 19.05 |
Low | 18.55 | 19.21 | 19.01 | 19.00 |
Performance
1 day | -0.03% | ||
1 week | -7.27% | ||
Current month | -7.27% | ||
1 month | -6.86% | ||
3 months | -2.39% | ||
6 months | +14.51% | ||
Current year | +13.88% | ||
1 year | +19.50% | ||
3 years | -5.12% | ||
5 years | -13.94% | ||
10 years | -22.91% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.03% | -7.27% | +13.88% | +19.50% | 84.52B | ||
+1.52% | +3.61% | +45.82% | +90.73% | 765B | ||
+1.10% | +6.11% | +40.95% | +79.07% | 632B | ||
+0.45% | +0.28% | -6.16% | -8.22% | 354B | ||
+0.11% | +4.09% | +19.86% | +18.45% | 331B | ||
+0.50% | +5.07% | +9.32% | +23.09% | 299B | ||
-0.27% | +3.00% | +18.45% | +6.86% | 248B | ||
+1.89% | +5.02% | -0.78% | -14.56% | 219B | ||
-0.04% | +1.91% | +11.88% | +5.07% | 216B | ||
-0.22% | -0.27% | +5.90% | +38.17% | 164B | ||
-0.76% | -0.28% | -0.73% | -26.89% | 162B | ||
+0.13% | +1.53% | +1.53% | -4.52% | 123B | ||
+1.47% | +0.95% | -19.16% | -36.49% | 84.08B | ||
+1.33% | +0.67% | -20.13% | -17.47% | 80.61B | ||
+0.97% | +4.50% | +50.54% | +22.97% | 71.16B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | +0.51% | +2.56% | +11.41% | +13.05% | ||
Weighted average by Cap. | +0.69% | +3.33% | +20.26% | +33.72% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +13.88% | ||
2023 | +2.73% | ||
2022 | -33.85% | ||
2021 | +27.71% | ||
2020 | -27.26% | ||
2019 | +27.12% | ||
2018 | +10.86% | ||
2017 | -18.55% | ||
2016 | -1.81% | ||
2015 | +5.76% | ||
2014 | -7.89% | ||
2013 | +15.64% | ||
2012 | -5.05% | ||
2011 | +16.90% | ||
2010 | +2.39% | ||
2009 | +14.01% | ||
2008 | -26.78% | ||
2007 | -11.81% | ||
2006 | -7.87% | ||
2005 | +24.86% | ||
2004 | -3.89% | ||
2003 | +4.77% | ||
2002 | -38.64% | ||
2001 | -5.41% | ||
2000 | 0.00% |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock
- Quotes GSK plc